163 related articles for article (PubMed ID: 7713566)
1. Protective role of interferon gamma, tumor necrosis factor alpha and interleukin-6 in Mycobacterium tuberculosis and M. avium infections.
Appelberg R
Immunobiology; 1994 Oct; 191(4-5):520-5. PubMed ID: 7713566
[TBL] [Abstract][Full Text] [Related]
2. Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection.
Doherty TM; Sher A
J Immunol; 1997 May; 158(10):4822-31. PubMed ID: 9144497
[TBL] [Abstract][Full Text] [Related]
3. Effector mechanisms involved in cytokine-mediated bacteriostasis of Mycobacterium avium infections in murine macrophages.
Appelberg R; Orme IM
Immunology; 1993 Nov; 80(3):352-9. PubMed ID: 8288311
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of IL-12 in immunotherapy and vaccine design in experimental Mycobacterium avium infections.
Silva RA; Pais TF; Appelberg R
J Immunol; 1998 Nov; 161(10):5578-85. PubMed ID: 9820535
[TBL] [Abstract][Full Text] [Related]
5. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection.
Appelberg R; Castro AG; Pedrosa J; Silva RA; Orme IM; Minóprio P
Infect Immun; 1994 Sep; 62(9):3962-71. PubMed ID: 8063414
[TBL] [Abstract][Full Text] [Related]
6. [Differential growth inhibition of mycobacteria by interferon-gamma-or tumor necrosis factor-alpha-treated murine peritoneal macrophages].
Sato K; Tomioka H; Saito H
Kekkaku; 1996 Nov; 71(11):607-14. PubMed ID: 8958673
[TBL] [Abstract][Full Text] [Related]
7. Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium.
Flórido M; Borges M; Yagita H; Appelberg R
J Leukoc Biol; 2004 Nov; 76(5):1039-46. PubMed ID: 15316035
[TBL] [Abstract][Full Text] [Related]
8. The relative impact of bacterial virulence and host genetic background on cytokine expression during Mycobacterium avium infection of mice.
Castro AG; Minóprio P; Appelberg R
Immunology; 1995 Aug; 85(4):556-61. PubMed ID: 7558149
[TBL] [Abstract][Full Text] [Related]
9. Endogenously produced IL-12 is required for the induction of protective T cells during Mycobacterium avium infections in mice.
Castro AG; Silva RA; Appelberg R
J Immunol; 1995 Aug; 155(4):2013-9. PubMed ID: 7636252
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Mycobacterium avium growth in vivo by cytokines: involvement of tumour necrosis factor in resistance to atypical mycobacteria.
Denis M
Clin Exp Immunol; 1991 Mar; 83(3):466-71. PubMed ID: 1900745
[TBL] [Abstract][Full Text] [Related]
11. Role of cytokines in tuberculosis.
Flesch IE; Kaufmann SH
Immunobiology; 1993 Nov; 189(3-4):316-39. PubMed ID: 8125515
[TBL] [Abstract][Full Text] [Related]
12. Bidirectional effects of cytokines on the growth of Mycobacterium avium within human monocytes.
Shiratsuchi H; Johnson JL; Ellner JJ
J Immunol; 1991 May; 146(9):3165-70. PubMed ID: 1901893
[TBL] [Abstract][Full Text] [Related]
13. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.
Yamamoto N; Zou JP; Li XF; Takenaka H; Noda S; Fujii T; Ono S; Kobayashi Y; Mukaida N; Matsushima K
J Immunol; 1995 Mar; 154(5):2281-90. PubMed ID: 7868900
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD3 single-chain Fv/interleukin-18 fusion DNA induces anti-mycobacterial resistance via efficient interferon-gamma production in BALB/c mice infected with Mycobacterium avium.
Kim SH; Cho D; Kim TS
Vaccine; 2006 Apr; 24(16):3365-73. PubMed ID: 16481075
[TBL] [Abstract][Full Text] [Related]
15. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
16. [Up-to-date understanding of tuberculosis immunity].
Mitsuyama M; Akagawa K; Kobayashi K; Sugawara I; Kawakami K; Yamamoto S; Okada Z
Kekkaku; 2003 Jan; 78(1):51-5. PubMed ID: 12683337
[TBL] [Abstract][Full Text] [Related]
17. Recombinant tumour necrosis factor-alpha decreases whereas recombinant interleukin-6 increases growth of a virulent strain of Mycobacterium avium in human macrophages.
Denis M; Gregg EO
Immunology; 1990 Sep; 71(1):139-41. PubMed ID: 2120128
[TBL] [Abstract][Full Text] [Related]
18. Role of interleukin-6 in the induction of protective T cells during mycobacterial infections in mice.
Appelberg R; Castro AG; Pedrosa J; Minóprio P
Immunology; 1994 Jul; 82(3):361-4. PubMed ID: 7959868
[TBL] [Abstract][Full Text] [Related]
19. Mitogen-activated protein kinases p38 and ERK1/2 regulated control of Mycobacterium avium replication in primary murine macrophages is independent of tumor necrosis factor-α and interleukin-10.
Klug K; Ehlers S; Uhlig S; Reiling N
Innate Immun; 2011 Oct; 17(5):470-85. PubMed ID: 20682586
[TBL] [Abstract][Full Text] [Related]
20. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection.
Cooper AM; Roberts AD; Rhoades ER; Callahan JE; Getzy DM; Orme IM
Immunology; 1995 Mar; 84(3):423-32. PubMed ID: 7751026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
